Real-time Estimate Tradegate 07:43:42 2024-06-05 am EDT 5-day change 1st Jan Change
47.8 EUR -0.42% Intraday chart for Stratec SE +4.92% +5.27%
Sales 2024 * 266M 289M Sales 2025 * 290M 315M Capitalization 583M 635M
Net income 2024 * 16M 17.4M Net income 2025 * 23M 25.02M EV / Sales 2024 * 2.63 x
Net Debt 2024 * 116M 126M Net Debt 2025 * 79.62M 86.61M EV / Sales 2025 * 2.29 x
P/E ratio 2024 *
35.8 x
P/E ratio 2025 *
25.1 x
Employees 1,473
Yield 2024 *
1.81%
Yield 2025 *
1.89%
Free-Float 59.43%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.16%
1 week+3.56%
Current month+0.73%
1 month+12.94%
3 months+10.09%
6 months+24.35%
Current year+5.38%
More quotes
1 week
45.65
Extreme 45.65
48.60
1 month
40.55
Extreme 40.55
48.60
Current year
36.25
Extreme 36.25
48.60
1 year
36.00
Extreme 36
69.00
3 years
36.00
Extreme 36
147.40
5 years
36.00
Extreme 36
147.40
10 years
35.05
Extreme 35.05
147.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 98-02-28
Director of Finance/CFO 57 98-04-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 58 19-05-28
Chairman 66 22-05-19
Director/Board Member 71 20-07-20
More insiders
Date Price Change Volume
24-06-05 47.95 -0.10% 167
24-06-04 48 0.00% 5,210
24-06-03 48 +0.73% 7,508
24-05-31 47.65 +2.14% 23,177
24-05-30 46.65 +2.08% 7,201

Delayed Quote Xetra, June 04, 2024 at 11:35 am EDT

More quotes
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
48 EUR
Average target price
42.33 EUR
Spread / Average Target
-11.81%
Consensus

Quarterly revenue - Rate of surprise